Infect Immun 60(12): 5219-5223
Streptococcal C5a peptidase is a highly specific endopeptidase.
Abstract
Compositional analysis of streptococcal C5a peptidase (SCPA) cleavage products from a synthetic peptide corresponding to the 20 C-terminal residues of C5a demonstrated that the target cleavage site is His-Lys rather than Lys-Asp, as previously suggested. A C5a peptide analog with Lys replaced by Gln was also subject to cleavage by SCPA. This confirmed that His-Lys rather than Lys-Asp is the scissile bond. Cleavage at histidine is unusual but is the same as that suggested for a peptidase produced by group B streptococci. Native C5 protein was also resistant to SCPA, suggesting that the His-Lys bond is inaccessible prior to proteolytic cleavage by C5 convertase. These experiments showed that the streptococcal C5a peptidase is highly specific for C5a and suggest that its function is not merely to process protein for metabolic consumption but to act primarily to eliminate this chemotactic signal from inflammatory foci.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (966K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Images in this article
Click on the image to see a larger version.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beachey EH, Tartar A, Seyer JM, Chedid L. Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein. Proc Natl Acad Sci U S A. 1984 Apr;81(7):2203–2207.[PMC free article] [PubMed] [Google Scholar]
- Bohnsack JF, Mollison KW, Buko AM, Ashworth JC, Hill HR. Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus. Biochem J. 1991 Feb 1;273(Pt 3):635–640.[PMC free article] [PubMed] [Google Scholar]
- Chen CC, Cleary PP. Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes. J Biol Chem. 1990 Feb 25;265(6):3161–3167. [PubMed] [Google Scholar]
- Chenoweth DE, Hugli TE. Human C5a and C5a analogs as probes of the neutrophil C5a receptor. Mol Immunol. 1980 Feb;17(2):151–161. [PubMed] [Google Scholar]
- Cleary PP, Peterson J, Chen C, Nelson C. Virulent human strains of group G streptococci express a C5a peptidase enzyme similar to that produced by group A streptococci. Infect Immun. 1991 Jul;59(7):2305–2310.[PMC free article] [PubMed] [Google Scholar]
- Fernandez HN, Hugli TE. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a. J Biol Chem. 1978 Oct 10;253(19):6955–6964. [PubMed] [Google Scholar]
- Fischetti VA. Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev. 1989 Jul;2(3):285–314.[PMC free article] [PubMed] [Google Scholar]
- Grathwohl C, Wüthrich K. Nmr studies of the molecular conformations in the linear oligopeptides H-(L-Ala)n-L-Pro-OH. Biopolymers. 1976 Oct;15(10):2043–2057. [PubMed] [Google Scholar]
- Heath DG, Cleary PP. Fc-receptor and M-protein genes of group A streptococci are products of gene duplication. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4741–4745.[PMC free article] [PubMed] [Google Scholar]
- Hill HR, Bohnsack JF, Morris EZ, Augustine NH, Parker CJ, Cleary PP, Wu JT. Group B streptococci inhibit the chemotactic activity of the fifth component of complement. J Immunol. 1988 Nov 15;141(10):3551–3556. [PubMed] [Google Scholar]
- O'Connor SP, Cleary PP. Localization of the streptococcal C5a peptidase to the surface of group A streptococci. Infect Immun. 1986 Aug;53(2):432–434.[PMC free article] [PubMed] [Google Scholar]
- Pancholi V, Fischetti VA. Isolation and characterization of the cell-associated region of group A streptococcal M6 protein. J Bacteriol. 1988 Jun;170(6):2618–2624.[PMC free article] [PubMed] [Google Scholar]
- Plaut AG. The IgA1 proteases of pathogenic bacteria. Annu Rev Microbiol. 1983;37:603–622. [PubMed] [Google Scholar]
- Siezen RJ, de Vos WM, Leunissen JA, Dijkstra BW. Homology modelling and protein engineering strategy of subtilases, the family of subtilisin-like serine proteinases. Protein Eng. 1991 Oct;4(7):719–737. [PubMed] [Google Scholar]
- Vos P, Boerrigter IJ, Buist G, Haandrikman AJ, Nijhuis M, de Reuver MB, Siezen RJ, Venema G, de Vos WM, Kok J. Engineering of the Lactococcus lactis serine proteinase by construction of hybrid enzymes. Protein Eng. 1991 Apr;4(4):479–484. [PubMed] [Google Scholar]
- Vos P, Simons G, Siezen RJ, de Vos WM. Primary structure and organization of the gene for a procaryotic, cell envelope-located serine proteinase. J Biol Chem. 1989 Aug 15;264(23):13579–13585. [PubMed] [Google Scholar]
- Wexler DE, Chenoweth DE, Cleary PP. Mechanism of action of the group A streptococcal C5a inactivator. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8144–8148.[PMC free article] [PubMed] [Google Scholar]
- Wexler DE, Cleary PP. Purification and characteristics of the streptococcal chemotactic factor inactivator. Infect Immun. 1985 Dec;50(3):757–764.[PMC free article] [PubMed] [Google Scholar]
- Wexler DE, Nelson RD, Cleary PP. Human neutrophil chemotactic response to group A streptococci: bacteria-mediated interference with complement-derived chemotactic factors. Infect Immun. 1983 Jan;39(1):239–246.[PMC free article] [PubMed] [Google Scholar]